“…Serotypes 1, 2 and 3 of wild-type PVs have been reported to recombine with each other (Dahourou et al, 2002;Furione et al, 1993). Wild-type and OPV strains have been reported to recombine (Dahourou et al, 2002;Georgescu et al, 1995;Guillot et al, 2000;Liu et al, 2000Liu et al, , 2003Yang et al, 2003) and PVs have been shown to recombine with serotypes of HEV-C (Brown et al, 2003;Jiang et al, 2007;Rousset et al, 2003). Furthermore, vaccine-derived PV strains, defined as having more than 1 % nucleotide differences in the VP1 protein coding region (reviewed recently by Agol, 2006;Kew et al, 2004), have been reported to have an interserotypic recombinant genome (Blomqvist et al, , 2004Martin et al, 2002) as well as a recombinant genome with a non-structural region from an unknown HEV-C strain (Arita et al, 2005;Kew et al, 2002Kew et al, , 2004Rakoto-Andrianarivelo et al, 2008;Rousset et al, 2003;Shimizu et al, 2004).…”